Harrow, Inc. is a Nashville ... it is also the only one with a J-code in the U.S. With ~17 million domestic use cases (primarily cataract surgeries and intravitreal injections) in 2023, management ...

"Following Harrow’s investment in the restoration of ... off-label options they had been forced to use while TRIESENCE was unavailable. This news, which allows for the reimbursement of TRIESENCE ...